Excessive, insufficient, or untimely apoptosis may result in disorders of cell numbers. Peritoneal demesothelization is an example of disease by decreased cell number; untimely leukocyte apoptosis impairs peritoneal defense. Conventional peritoneal dialysis solutions accelerate neutrophil apoptosis. Glucose degradation products such as 3,4-dideoxyglucosone-3-ene (3,4-DGE) decisively contribute to apoptosis induced by these solutions, in both leukocytes and mesothelial cells and in both culture and peritoneal dialysis patients. Pan-caspase inhibition retards neutrophil apoptosis and improves peritoneal clearance of Staphylococcus aureus in animal models. However, regulation of apoptosis in mesothelial cells is more complex than in leukocytes, and caspase inhibitors may not be the optimal drugs to modulate apoptosis in these cells. In this regard, Bax antagonistic peptides protect mesothelial cells from 3,4-DGE. In addition, novel molecular targets have been identified. Short-term modulation of apoptosis may be useful to accelerate recovery and to prevent irreversible peritoneal injury following peritonitis.
OrtizA., CatalanM.P.Will modulation of cell death increase PD technique survival?Perit Dial Int2004; 24: 105–14.
4.
CatalánM.P., EstebanJ., SubiráD., EgidoJ., OrtizA.Inhibition of caspases improves bacterial clearance in experimental peritonitis.Perit Dial Int2003; 23: 123–6.
5.
CatalanM.P., SubiráD., ReyeroA., SelgasR., OrtizA., EgidoJ.Regulation of apoptosis by lethal cytokines in human mesothelial cells.Kidney Int2003; 64: 321–30.
6.
SantamaríaB., UceroA.C., ReyeroA., SelgasR., Ruiz-OrtegaM., CatalánM.3,4-di-deoxyglucosone-3-ene as a mediator of peritoneal demesothelization.Nephrol Dial Transplant2008; 23: 3307–15.
7.
CatalánM.P., ReyeroA., EgidoJ., OrtizA.Acceleration of neutrophil apoptosis by glucose-containing peritoneal dialysis solutions: role of caspases.J Am Soc Nephrol2001; 12: 2442–9.
8.
Di PaoloN., SacchiG.Atlas of peritoneal histology.Perit Dial Int2000; 20(Suppl 3): S5–96.
9.
VergerC., LugerA., MooreH.L., NolphK.D.Acute changes in peritoneal morphology and transport properties with infectious peritonitis and mechanical injury.Kidney Int1983; 23: 823–31.
10.
Yanez-MoM., Lara-PezziE., SelgasR., Ramirez-HuescaM., Dominguez-JimenezC., Jimenez-HeffernanJ.A.Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells.N Engl J Med2003; 348: 403–13.
11.
WitowskiJ., WisniewskaJ., KorybalskaK., BenderT.O., BreborowiczA., GahlG.M.Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells.J Am Soc Nephrol2001; 12: 2434–41.
12.
CendorogloM., SundaramS., GrovesC., UcciA.A., JaberB.L., PereiraB.J.Necrosis and apoptosis of polymorphonuclear cells exposed to peritoneal dialysis fluids in vitro.Kidney Int1997; 52: 1626–34.
OrtizA., ZiyadehF.N., NeilsonE.G.Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys.J Invest Med1997; 45: 50–6.
LindenT., CohenA., DeppischR., KjellstrandP., WieslanderA.3,4-dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis.Kidney Int2002; 62: 697–703.
17.
OrtizA., WieslanderA., LindenT., SantamariaB., SanzA., JustoP.3,4-DGE is important for side effects in peritoneal dialysis what about its role in diabetes.Curr Med Chem2006; 13: 2695–702.
18.
ErixonM., LindenT., KjellstrandP., CarlssonO., ErnebrantM., ForsbackG.PD fluids contain high concentrations of cytotoxic GDPs directly after sterilization.Perit Dial Int2004; 24: 392–8.
19.
AmoreA., CappelliG., CirinaP., ContiG., GambarutoC., SilvestroL.Glucose degradation products increase apoptosis of human mesothelial cells.Nephrol Dial Transplant2003; 18: 677–88.
20.
BoulangerE., WautierM.P., GaneP., MarietteC., DevuystO., WautierJ.L.The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products.Nephrol Dial Transplant2004; 19: 2208–16.
21.
WeltenA.G., SchalkwijkC.G., ter WeeP.M., MeijerS., van den BornJ., BeelenR.J.Single exposure of mesothelial cells to glucose degradation products (GDPs) yields early advanced glycation end-products (AGEs) and a proinflammatory response.Perit Dial Int2003; 23: 213–21.
22.
WieslanderA.P., AndrenA.H., Nilsson-ThorellC., MuscaluN., KjellstrandP.T., RippeB.Are aldehydes in heat-sterilized peritoneal dialysis fluids toxic in vitro?Perit Dial Int1995; 15: 348–52.
LorzC., Benito-MartínA., BoucherotA., UceroA.C., RastaldiM.P., HengerA.The death ligand TRAIL in diabetic nephropathy.J Am Soc Nephrol2008, 19: 904–14.
29.
JustoP., SanzA.B., Sanchez-NinoM.D., WinklesJ.A., LorzC., EgidoJ.Cytokine cooperation in renal tubular cell injury: the role of TWEAK.Kidney Int2006; 70: 1750–8.
BenM.T., BarashH., KangT.B., KimJ.C., KovalenkoA., GrossE.Role of caspase-8 in hepatocyte response to infection and injury in mice.Hepatology2007; 45: 1014–24.
33.
MaletG., MartinA.G., OrzaezM., VicentM.J., MasipI., SanclimensG.Small molecule inhibitors of Apaf-1-related caspase-3/-9 activation that control mitochondrial-dependent apoptosis.Cell Death Differ2006; 13: 1523–32.
34.
HotchkissR.S., McConnellK.W., BullokK., DavisC.G., ChangK.C., SchwulstS.J.TAT-BH4 and TAT-Bcl-xL peptides protect against sepsis-induced lymphocyte apoptosis in vivo.J Immunol2006; 176: 5471–7.
